首页> 外国专利> METFORMIN HYDROCHLORIDE/BERBERINE HYDROCHLORIDE COMPOUND SUSTAINED-RELEASE SUSPENSION PREPARATION AND PREPARATION METHOD THEREFOR

METFORMIN HYDROCHLORIDE/BERBERINE HYDROCHLORIDE COMPOUND SUSTAINED-RELEASE SUSPENSION PREPARATION AND PREPARATION METHOD THEREFOR

机译:盐酸二甲双胍/盐酸小BER碱缓释缓释复合物的制备及制备方法

摘要

The present invention discloses a metformin hydrochloride/berberine hydrochloride compound sustained-release suspension preparation and a preparation method therefor. The compound sustained-release suspension preparation is mainly prepared from a cation exchange resin, metformin hydrochloride, berberine hydrochloride, an impregnating agent, a plasticizer, a suspending aid, and other excipients. Compared with the prior art, the metformin hydrochloride/berberine hydrochloride compound sustained-release suspension preparation obtained by the present invention is convenient to administer, and can be administered in divided doses, thereby resolving the problem of difficulty for a patient in swallowing oral solid sustained-release preparations prepared from large-dose drugs. The present invention creates a multi-unit drug release system in which a release behavior is the sum of individual microparticle drug release behaviors, achieving better reproducibility and consistency, and avoiding a situation in which oral solid sustained-release preparations are prone to cause excessive local concentrations after fragmentation.
机译:本发明公开了一种盐酸二甲双胍/盐酸小ber碱化合物缓释混悬剂及其制备方法。化合物缓释混悬剂主要由阳离子交换树脂,盐酸二甲双胍,盐酸小ber碱,浸渍剂,增塑剂,助悬剂和其他赋形剂制备。与现有技术相比,本发明得到的盐酸二甲双胍/盐酸小ber碱化合物缓释混悬液制剂给药方便,可以分次给药,解决了患者吞咽口服固体持续给药困难的问题。大剂量药物制成的缓释制剂。本发明创造了一种多单位药物释放系统,其中释放行为是单个微粒药物释放行为的总和,实现了更好的再现性和一致性,并且避免了口服固体缓释制剂易于引起局部过量使用的情况。碎片后的浓度。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号